TRP-8803
Fibromyalgia, IBS, Binge Eating Disorder, Depression, Pain, OCD
Phase 1Active
Key Facts
Indication
Fibromyalgia, IBS, Binge Eating Disorder, Depression, Pain, OCD
Phase
Phase 1
Status
Active
Company
About Tryptamine Therapeutics
Australian‑based biotech delivering IV psilocin therapies for neuropsychiatric disorders.
View full company profile